KYLYS is an innovative Swiss company based in Geneva founded in March 2017. KYLYS aims at providing people and patients with highly effective and safe products based on biomolecules.
GHIA 2018 – First Runner-up
Proud to announce that our startup KYLYS won the 2nd prize in the Global Healthcare Innovation Academy (GHIA) in Hong-Kong for its new approach to treat osteoarthritis!...
More Information
Global Healthcare Innovation Academy – 29.08.2018
We have been selected as one of the best innovations in health and healthcare from Switzerland. Thus, we presented our technology to the Global Healthcare Innovation...
More Information
Exclusive worldwide license – 08.09.2017
KYLYS is assigned exclusive worldwide rights by University of Geneva on an innovative technology based on hyaluronic acid (HA). HA, a naturally occurring biocompatible...
More Information
Controlled Release Society (CRS) 44th Annual Meeting & Exposition – 16.07.2017
We have presented our technology to a prestigious international meeting: the 44th Annual Meeting & Exposition of the Controlled Release Society in Boston,...
More Information
International Conference on Advances in Basic, Applied and Clinical Science of Hyaluronan – 11.06.2017
We have presented our technology to the most important world hyaluronan conference in Cleveland, Ohio, United...
More Information
From researcher to entrepreneur – 02.05.2017
We have presented our experience “from researcher to entrepreneur” to a packed audience at the Centre Médical Universitaire on Tuesday, 2nd of May 2017,...
More Information
First Innovation Award & Startup Award – 20.10.2016
Every year since 2007 the University Hospital of Geneva (HUG), in partnership with the Geneva Faculty of Medicine, has organized Innovation Days where a...
More Information